Showing results (3041-3050 of 3,091) with videos related to

Sort By:
Pageof 310
Drug Safety|August 15, 2020
Temelimab, an IgG4 Anti-Human Endogenous Retrovirus Monoclonal Antibody: An Early Development Safety ReviewGabrielle Kornmann, François Curtin
Drug Safety|October 16, 2012
Adverse drug reactions: when the risk becomes a reality for patientsAnthony R Cox, Tehreem F Butt
Drug Safety|October 16, 2012
Risk perception and communication in sub-Saharan AfricaAlexander Dodoo, Bruce Hugman
Drug Safety|October 16, 2012
The globalization of risk and risk perception: why we need a new model of risk communication for vaccinesHeidi Larson, Pauline Brocard Paterson, Ngozi Erondu
Drug Safety|October 16, 2012
Healthcare professionals' self-reported experiences and preferences related to direct healthcare professional communications: a survey conducted in the NetherlandsSigrid Piening, Flora M Haaijer-Ruskamp, Pieter A de Graeff, et al.
Drug Safety|October 20, 2012
Balancing the risks and benefits of the use of over-the-counter pain medications in childrenZeina Bárzaga Arencibia, Imti Choonara
Drug Safety|August 8, 2025
A Scoping Review of Published Literature on the Contributions of the Natural Health Products (NHPs) Industry to Pharmacovigilance for NHPsXin Yi Lim, Sanyogita Ram, Shane Scahill, et al.
Drug Safety|October 25, 2025
Strengthening Signal Detection in Pharmacovigilance by Using International Nonproprietary Name (INN) StemsRaffaella Balocco, Jeffrey K Aronson, Sarel F Malan, et al.
Drug Safety|July 2, 2025
Signals of Adverse Reactions to Herbal Medicines: Evidence and Document Analysis Based on a Scoping ReviewDaniele Sartori, Jeffrey K Aronson, Judith S Brand, et al.
Drug Safety|June 30, 2025
Characteristics of Drug-RElated Hospitalizations for Nursing HOme Residents: Cross-Sectional RENHO StudyAlice Lopez, Chiara Alfarano, Marianne Lepetit, et al.
Pageof 310